½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹CDKN2B¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹CDKN2B¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW5658
    • Ó¦Óà : ½öÓÃÓÚ¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£ºÍÿ¹CDKN2B¶à¿Ë¡¿¹Ìå

Ó¢ÎÄÃû³Æ£º
Anti-CDKN2B rabbit polyclonal antibody

±ð      Ãû£º P15; MTS2; TP15; CDK4I; INK4B; p15INK4b

Ïà¹ØÀà±ð£º Ò»¿¹

´¢      ´æ£º
Àä¶³£¨-20¡æ£© ±Ü¹â

¿¹      Ô­£º CDKN2B

ËÞ      Ö÷£º Rabbit

·´Ó¦ÖÖÊô£º Human Mouse Rat

±ê ¼Ç Î Unconjugate

¿Ë¡ÀàÐÍ£º
Unconjugate

¼¼Êõ¹æ¸ñ

Background:

This gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated and deleted in a wide variety of tumors. This gene encodes a cyclin-dependent kinase inhibitor, which forms a complex with CDK4 or CDK6, and prevents the activation of the CDK kinases, thus the encoded protein functions as a cell growth regulator that controls cell cycle G1 progression.

Applications:

WB, IHC, IF

Name of antibody:

CDKN2B

Immunogen:

Synthesized peptide derived from human p15 INK antibody.

Full name:

cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)

Synonyms£º

P15; MTS2; TP15; CDK4I; INK4B; p15INK4b

SwissProt:

P42772

IHC positive control:

Human lung carcinoma tissue

IHC Recommend dilution:

50-100

WB Predicted band size:

15 kDa

WB Positive control:

Hela cells lysate

WB Recommended dilution:

500-3000

IF positive control:

Hela cells

IF Recommend dilution:

100-500









¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿